A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma (Q65466148)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma
clinical trial

    Statements

    ANNOUNCE 2 (English)
    0 references
    A Phase 1b (Open-Label)/Phase 2 (Randomized, Double-Blinded) Study Evaluating Gemcitabine and Docetaxel With or Without Olaratumab in the Treatment of Advanced Soft Tissue Sarcoma (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    2 March 2016
    0 references
    December 2019
    0 references
    310
    0 references
    16 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit